Patents by Inventor György Újfalussy

György Újfalussy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL FORMULATION HAVING IMPROVED STABILITY
    Publication number: 20150094345
    Abstract: The present invention is related to a pharmaceutical formulation containing ramipril with improved stability, which comprises ramipril and a desintegrant directly granulated with a binder.
    Type: Application
    Filed: February 17, 2012
    Publication date: April 2, 2015
    Applicant: EGIS GYOGYSZERGYAR ZRT.
    Inventors: Andras Feher, Zsolt Zsigmond, György Újfalussy, Péter Tonkanagy, György Morovjan
  • Granulating process and thus prepared granulate
    Patent number: 8927021
    Abstract: The present invention relates to a process for manufacturing microcrystalline ezetimibe containing granulate, wherein a) ezetimibe is dissolved; b) the dissolved ezetimibe is precipitated with water, which if necessary contains pharmaceutical excipients, preferably lauryl-sulfate derivatives, and c) granulates are formed from the obtained suspension by spraying the suspension onto pharmaceutical excipients. A further aspect of the present invention is the granulate obtained by the present process and the pharmaceutical composition containing such granulate.
    Type: Grant
    Filed: February 24, 2010
    Date of Patent: January 6, 2015
    Assignee: Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszventarsasag
    Inventors: Zoltan Toelgyesi, Zsolt Zsigmond, Gyoergy Ujfalussy, Magdolna Leventiszne Huszar, Peter Tonka-Nagy, Monika Agyagos
  • NEW GRANULATING PROCESS AND THUS PREPARED GRANULATE
    Publication number: 20120164227
    Abstract: The present invention relates to a process for manufacturing microcrystalline ezetimibe containing granulate, wherein a) ezetimibe is dissolved; b) the dissolved ezetimibe is precipitated with water, which if necessary contains pharmaceutical excipients, preferably lauryl-sulfate derivatives, and c) granulates are formed from the obtained suspension by spraying the suspension onto pharmaceutical excipients. A further aspect of the present invention is the granulate obtained by the present process and the pharmaceutical composition containing such granulate.
    Type: Application
    Filed: February 24, 2010
    Publication date: June 28, 2012
    Inventors: Zoltan Toelgyesi, Zsolt Zsigmond, Gyoergy Ujfalussy, Magdolna Leventiszne Huszar, Peter Tonka-Nagy, Monika Agyagos